PICOT: Non-Compliance in Diabetic Patients Analysis

PICOT: Non-compliance in Diabetic Patients
Your Name
Your Institution of Affiliation
August 3, 2017
Introduction
According to the WHO, one of the most persistent and serious illness that affects a significant percentage of today’s population is diabetes (Castillo, 2012). It is estimated that as of 2012, about 371 million people in the world is diagnosed with diabetes, while the undiagnosed cases reach to about the same number. Although diabetes can both be inherited as well as developed during the course of a person’s life, what is alarming is that diabetes type II (the preventable case) is more widespread, affecting about 90% of the population of the people with diabetes around the whole world. This then puts into question the effectiveness of current assessment methods and educative procedures, which are established in order to prevent the widespread of diabetes in the whole world. Nevertheless, due to the limited time and resources, this article would narrow down its focus towards the effectivity of the assessment methods and educative procedures in decreasing the “non-compliance” of patients, diagnosed with diabetes, with their diabetes medication and other treatments. This, in itself, is a serious matter to be discussed in the field of healthcare, since a study has shown that noncompliance (or non-adherence), in the treatment (especially those who are getting insulin treatment) have a higher morbidity rate than people who comply or even those who don’t start treatments at all (Currie, et al., 2012). This study is done by Currie, et al. (2012), where the researchers utilized the data from general practice records of about 16 thousand patients which are diagnosed with diabetes type II. Noncompliance, as the r...